Falun Gong and Victims of Forced Organ Harvesting Protection Act
SB4009, the Falun Gong and Victims of Forced Organ Harvesting Protection Act, would create a U.S. sanctions regime targeting foreign persons who knowingly and directly engage in or facilitate forced organ harvesting in the People’s Republic of China. Within 180 days of enactment, the President would be required to submit to Congress a list of covered individuals or entities, with updates at least annually, and then impose blocking sanctions on property and interests in property subject to U.S. jurisdiction. The bill also makes listed persons inadmissible to the United States, revokes existing visas or entry documents, and authorizes penalties for violations of implementing regulations.
In addition to sanctions, the bill directs the Secretary of State, in consultation with HHS and NIH, to produce a report on China’s organ transplant policies and practices. That report must address transplant practices involving prisoners of conscience, including Falun Gong practitioners, estimate transplant volumes and donor sources, assess how quickly organs are procured in China, identify U.S. grants supporting transplant research involving Chinese entities, and determine whether forced organ harvesting constitutes an atrocity under existing U.S. law. The bill also excludes sanctions from applying to humanitarian transactions, agricultural commodities, food, medicine, intelligence activities, law enforcement activities, and cases where waivers are necessary for U.S. national security interests.
The bill would amend federal sanctions and immigration enforcement practice by adding a China-focused human-rights sanctions authority tied to organ harvesting abuses. It relies on the International Emergency Economic Powers Act framework for blocking property and on Immigration and Nationality Act authorities for visa denial and revocation. It also expressly states that the sanctions authority does not extend to importation of goods, and it sunsets five years after enactment.
The overall sentiment reflected in the bill’s movement is supportive and bipartisan in tone, as shown by its introduction by Senators Cruz and Merkley and the committee’s favorable ordering to report with an amendment in the nature of a substitute. No vote record or transcript is provided, so there is no direct evidence of floor debate or opposition in the supplied materials. The bill’s framing suggests strong concern about human rights abuses and support for accountability measures.
The main points of potential contention are the scope and evidentiary basis for identifying sanctioned persons, the use of sanctions and visa restrictions against foreign individuals and entities, and the bill’s findings-related report on China’s transplant system. Some may also question the implications for U.S.-China relations, the breadth of the waiver authority, and whether the reporting and sanctions framework could affect academic or medical collaboration involving Chinese institutions.
The bill would add a new federal sanctions and visa-restriction authority aimed at foreign persons involved in forced organ harvesting in China, while also requiring a detailed executive-branch report on China’s transplant policies and U.S.-linked research activity. It would not authorize sanctions on imported goods, and it preserves exceptions for humanitarian assistance, food, medicine, intelligence, law enforcement, and certain international-obligation cases. The measure would operate through existing sanctions and immigration statutes, expanding their use to a specific human-rights abuse and creating a five-year sunset for the authority.
The available context indicates generally favorable sentiment. The bill was introduced by Senators Cruz and Merkley and was ordered reported favorably by the Senate Committee on Foreign Relations with an amendment in the nature of a substitute, suggesting bipartisan or at least cross-party support for the underlying objective. No recorded votes or hearing transcript excerpts are provided, so there is no direct evidence of dissent in the supplied materials, but the subject matter points to a strong human-rights-driven consensus around condemning forced organ harvesting.
Likely areas of contention include whether the executive branch can reliably identify individuals who “knowingly and directly” engaged in or facilitated forced organ harvesting, how broadly sanctions should reach, and whether the reporting requirements could implicate U.S. medical or research partnerships with Chinese entities. Critics may also focus on the foreign-policy consequences of sanctions against Chinese officials or institutions, the breadth of visa revocation authority, and the balance between accountability and humanitarian or national-security exceptions. Supporters are likely to emphasize human rights, protection of Falun Gong practitioners and other victims, and the need for U.S. pressure on China’s transplant system.